By
Drug Target Review2025-07-01T14:41:16
AI is changing how clinical trials are run - quietly but significantly. Find out how digital twins are helping sponsors reduce control arms and accelerate development without changing trial endpoints.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-12T09:31:00Z
Contributor Sugish Pillai, Axel Ziemke and Dr Gary Kusdian
2026-06-02T15:00:00 2026-06-02T16:00:00
Sponsored by Danaher Life Sciences
2026-05-12T09:31:00
Contributor Sugish Pillai, Axel Ziemke and Dr Gary Kusdian
2023-03-23T14:46:21
Sponsored by Bio-Techne
2023-03-02T13:57:58
Sponsored by Cell Signaling Technology
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2025-09-24T14:00:00
Sponsored by Eurofins Discovery
Site powered by Webvision Cloud